Last reviewed · How we verify
NCT04551924
A Trial of HR18034 in Inguinal Hernia Repair
Phase 1 trial testing HR18034 in Inguinal Hernia Repair in 64 participants. Status unknown.
30 May 2021
Quick facts
| Lead sponsor | Jiangsu HengRui Medicine Co., Ltd. |
|---|---|
| Phase | Phase 1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 64 |
| Start date | 1 October 2020 |
| Primary completion | 30 May 2021 |
| Estimated completion | 30 May 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
Conditions studied
- Inguinal Hernia Repair — all drugs for Inguinal Hernia Repair →
Sponsor
Jiangsu HengRui Medicine Co., Ltd. — full company profile →
Who can join
Adults 18 to 70, any sex, with Inguinal Hernia Repair. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Phase I, randomized, double-blind, comparator-controlled study to assess the safety, PK, and efficacy of single postsurgical application of HR18034 compared with Naropin®
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04551924
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of HR18034
Trials testing the same drug.
- NCT06509958 — Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA · Phase 2 · terminated
- NCT05769855 — A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy · Phase 3 · completed
- NCT05744674 — Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management · Phase 2 · unknown
- NCT05376904 — A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy. · Phase 2 · completed
Other recruiting trials for Inguinal Hernia Repair
Currently open trials in the same condition.
- NCT07511764 — Comparison of Laryngeal Mask Airway Versus Endotracheal Intubation in Pediatric Laparoscopic Inguinal Hernia Repair: A M · NA · recruiting
- NCT07252999 — Comparison of Outcomes of Hernia Sac Transection and Sac Reduction in Open Pediatric Inguinal Hernia Repair in Ramathibo · NA · recruiting
Other Jiangsu HengRui Medicine Co., Ltd. trials
Trials by the same sponsor.
- NCT07252921 — Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults · Phase 2 · completed
- NCT07142850 — A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HR · Phase 1 · completed
- NCT07073157 — Effect of HRS-8427 for Injection on the Pharmacokinetics of Furosemide and Metformin in Healthy Subjects。 · Phase 1 · completed
- NCT07076459 — A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy · Phase 1 · completed
- NCT07049107 — Pharmacokinetics Impact of HRS-8427 on Bupropion and Midazolam in Healthy Subjects · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04551924 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jiangsu HengRui Medicine Co., Ltd.
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04551924.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing